Massachusetts’ largest hospital has agreed to pay $2.3 million to settle federal allegations that it violated the Controlled Substances Act.
On Tuesday, Massachusetts General Hospital, which is Harvard Medical School’s largest teaching hospital, agreed to settle with the U.S. government in a deal that also calls for it to adhere to a stringent compliance plan. One provision of the plan mandates using a fingerprint identification system for automatic drug-dispensing machines.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
